Steph & CO Pfizer Inc Transaction History

Steph & CO

  • $257 Million
  • Q2 2024

A detailed history of Steph & CO transactions in Pfizer Inc stock. As of the latest transaction made, Steph & CO holds 2,122 shares of PFE stock, worth $62,110. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,122
Previous 2,090 1.53%
Holding current value
$62,110
Previous $57,000 3.51%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$25.26 - $29.6 $808 - $947
32 Added 1.53%
2,122 $59,000
Q1 2024

Apr 12, 2024
SELL
$25.89 - $29.73 $170,407 - $195,682
-6,582 Reduced 75.9%
2,090 $57,000
Q4 2023

Jan 31, 2024
SELL
$26.13 - $33.94 $78,625 - $102,125
-3,009 Reduced 25.76%
8,672 $249,000
Q3 2023

Oct 26, 2023
BUY
$32.09 - $37.51 $90,012 - $105,215
2,805 Added 31.6%
11,681 $387,000
Q2 2023

Jul 14, 2023
BUY
$36.12 - $41.79 $258,221 - $298,756
7,149 Added 413.95%
8,876 $325,000
Q2 2022

Jul 13, 2022
SELL
$46.53 - $55.17 $29,639 - $35,143
-637 Reduced 26.95%
1,727 $91,000
Q4 2021

Jan 24, 2022
BUY
$41.32 - $61.25 $26,320 - $39,016
637 Added 36.88%
2,364 $140,000
Q3 2020

Oct 27, 2020
SELL
$31.75 - $37.25 $43,878 - $51,479
-1,382 Reduced 44.45%
1,727 $63,000
Q2 2020

Jul 15, 2020
SELL
$30.12 - $36.54 $160,901 - $195,196
-5,342 Reduced 63.21%
3,109 $102,000
Q1 2020

Apr 14, 2020
SELL
$27.03 - $38.62 $55,492 - $79,286
-2,053 Reduced 19.54%
8,451 $276,000
Q4 2019

Feb 24, 2020
BUY
$32.92 - $37.36 $345,791 - $392,429
10,504 New
10,504 $412,000

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $164B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Steph & CO Portfolio

Follow Steph & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email